Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Antibodies used in the study

From: Patient-derived tissue slice grafts accurately depict response of high-risk primary prostate cancer to androgen deprivation therapy

Name Source Dilution
Anti-cytokeratin 18 (K18) Santa Cruz Biotechnology, Santa Cruz, CA 1:200
Anti-AR BD Pharmingen, San Diego, CA 1:200
Anti-PSA Santa Cruz Biotechnology 1:100
Anti-AMACR/p63 Biocare, Concord, CA ready to use
Anti-Ki67 Biocare 1:100
Anti-Ku70 Abcam, Cambridge, MA 1:200
Anti-human specific-CD31 Dako Corp., Carpinteria, CA 1:20
Anti-CCNA Leica Microsystems, Buffalo Grove, IL 1:50
Anti-ERG Epitomics, Burlingame, CA 1:100
Anti-VIM Epitomics 1:100
Anti-TOP2A Dako Corp 1:50
universal biotinylated horse anti-mouse/rabbit IgG Vector Laboratories Inc., Burlingame, CA 1:1000
Alexa 488 goat anti-mouse Invitrogen, Carlsbad, CA 1:1000
Alexa 555 goat anti-rabbit Invitrogen 1:1000